BR0116415A - Indução de toler ncia - Google Patents

Indução de toler ncia

Info

Publication number
BR0116415A
BR0116415A BR0116415-5A BR0116415A BR0116415A BR 0116415 A BR0116415 A BR 0116415A BR 0116415 A BR0116415 A BR 0116415A BR 0116415 A BR0116415 A BR 0116415A
Authority
BR
Brazil
Prior art keywords
individual
present
antigenic
parts
antigenic material
Prior art date
Application number
BR0116415-5A
Other languages
English (en)
Inventor
Marco Turini
Bruce German
Sophie Pecquet
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170804&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0116415(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0116415A publication Critical patent/BR0116415A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Dairy Products (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Confectionery (AREA)
  • Fodder In General (AREA)

Abstract

"INDUçãO DE TOLER NCIA". A presente invenção pertence a um método para induzir tolerância a um material antigênico em um indivíduo administrando-se um composto aumentando a atividade de COX-2 (ciclo-oxigenase 2) nas células do indivíduo, em particular nas células envolvidas em uma reação imune, e opcionalmente também aumentando o nível de IFN-<sym>, e um material antigênico ou partes antigênicas deste, ao qual o indivíduo desenvolve reações imunes adversas. Especificadamente, a presente invenção pertence a uma composição farmacêutica ou alimentícia contendo tais compostos e o material antigênico ou partes deste. Em uma modalidade alternativa, a presente invenção também pertence a um novo método ex vivo para determinar uma tendência do indivíduo a desenvolver uma reação alérgica a um material particular.
BR0116415-5A 2000-12-22 2001-12-20 Indução de toler ncia BR0116415A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00128438 2000-12-22
PCT/EP2001/015129 WO2002051437A1 (en) 2000-12-22 2001-12-20 Induction of tolerance

Publications (1)

Publication Number Publication Date
BR0116415A true BR0116415A (pt) 2003-12-30

Family

ID=8170804

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0116415-5A BR0116415A (pt) 2000-12-22 2001-12-20 Indução de toler ncia

Country Status (20)

Country Link
US (1) US20030232057A1 (pt)
EP (1) EP1345624B1 (pt)
JP (1) JP2004522725A (pt)
KR (1) KR20030065539A (pt)
CN (1) CN1529618A (pt)
AR (1) AR031962A1 (pt)
AT (1) ATE330628T1 (pt)
BR (1) BR0116415A (pt)
CA (1) CA2431835A1 (pt)
DE (1) DE60121039T2 (pt)
ES (1) ES2267860T3 (pt)
IL (1) IL156276A0 (pt)
MX (1) MXPA03005643A (pt)
NO (1) NO20032732L (pt)
NZ (1) NZ526974A (pt)
PL (1) PL366226A1 (pt)
PT (1) PT1345624E (pt)
RU (1) RU2283665C2 (pt)
WO (1) WO2002051437A1 (pt)
ZA (1) ZA200305620B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1955602B1 (en) * 2003-09-12 2018-04-04 Nestec S.A. Milk fractions and milk preparations for treating and/or preventing COX-2 mediated diseases
DE602005016714D1 (de) * 2004-12-06 2009-10-29 Eastman Chem Co Cobaltkonzentrate auf polyesterbasis für sauerstoffspülende zusammensetzungen
US7375154B2 (en) * 2004-12-06 2008-05-20 Eastman Chemical Company Polyester/polyamide blend having improved flavor retaining property and clarity
MX2007006730A (es) * 2004-12-06 2008-02-15 Constar Int Inc Mezclas de poliamidas depuradoras de oxigeno con poliesteres que contienen zinc y cobalto.
US7572474B2 (en) 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8075934B2 (en) 2008-10-24 2011-12-13 Mead Johnson Nutrition Company Nutritional composition with improved digestibility
BRPI0618569A2 (pt) * 2005-11-14 2011-09-06 Nestec Sa promoção de toleráncia oral com proteìnas glicadas
EP2044851A1 (en) * 2007-09-26 2009-04-08 Nestec S.A. Prevention of allergy at weaning
US8986769B2 (en) 2008-10-24 2015-03-24 Mead Johnson Nutrition Company Methods for preserving endogenous TGF-β
US8367354B2 (en) 2008-10-24 2013-02-05 Mead Johnson Nutrition Company Methods for determining the levels of TGF-β in a composition
US8350006B2 (en) 2008-10-24 2013-01-08 Mead Johnson Nutrition Company Methods for determining the bioactivity of TGF-β in a composition
JP6429237B2 (ja) 2015-04-14 2018-11-28 国立大学法人京都大学 免疫寛容部位形成剤及び免疫抑制性細胞の誘引剤
MA46098A (fr) 2016-09-01 2019-07-10 Regeneron Pharma Méthodes de prévention ou de traitement de l'allergie par administration d'un antagoniste d'il-4 r
CA3132587A1 (en) 2019-03-21 2020-09-24 Regeneron Pharmaceuticals, Inc. Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH092958A (ja) * 1995-06-20 1997-01-07 Snow Brand Milk Prod Co Ltd ＩｇＥ産生促進組成物及びその利用

Also Published As

Publication number Publication date
CN1529618A (zh) 2004-09-15
ATE330628T1 (de) 2006-07-15
PT1345624E (pt) 2006-09-29
KR20030065539A (ko) 2003-08-06
NO20032732D0 (no) 2003-06-16
JP2004522725A (ja) 2004-07-29
AR031962A1 (es) 2003-10-08
PL366226A1 (en) 2005-01-24
EP1345624A1 (en) 2003-09-24
RU2283665C2 (ru) 2006-09-20
CA2431835A1 (en) 2002-07-04
MXPA03005643A (es) 2003-10-06
DE60121039D1 (de) 2006-08-03
ES2267860T3 (es) 2007-03-16
NZ526974A (en) 2006-07-28
DE60121039T2 (de) 2007-01-11
EP1345624B1 (en) 2006-06-21
ZA200305620B (en) 2004-10-21
IL156276A0 (en) 2004-01-04
RU2003122333A (ru) 2005-01-27
WO2002051437A1 (en) 2002-07-04
US20030232057A1 (en) 2003-12-18
NO20032732L (no) 2003-07-25

Similar Documents

Publication Publication Date Title
BR0116415A (pt) Indução de toler ncia
BR9910089A (pt) Composições e antìgenos de neisseria meningitidis
BR9814276A (pt) Antìgenos de superfìcie
ES2062310T3 (es) Un procedimiento para fabricar un preparado farmaceutico acuoso estabilizado.
MXPA05007211A (es) Composicion farmaceutica que comprende una region de fc de inmunoglobulina como un vehiculo.
BR0312276A (pt) Mimeticorpos ch1-removidos miméticos de epo de mamìfero, composições, métodos e usos
DK552684A (da) Desulfatohirudiner samt deres fremstilling og anvendelse
DK0625989T3 (da) DNA-sekvenser kodende for hidtil ukendte vækst-/differentieringsfaktorer
NZ217844A (en) A sustained release pharmaceutical composition containing silicone elastomer and an albumin
BR0209434A (pt) Peptìdeos antimicrobianos e composições
ATE131029T1 (de) Lagerstabile, permanent wasserbenetzbare vulkanisate ergebende polysiloxanmasse.
LU93259I2 (fr) LETIFEND (Protein Q)
DK431887A (da) Dna-forbindelse samt tpa-lignende protein
BR0316324A (pt) Polipeptìdeos e conjugados de interferon-alfa
PT84089A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
DK1133997T3 (da) Beta-interferon til behandling af immunsygdomme
DK0781344T3 (da) Hidtil ukendt implantat og hidtil ukendt vektor til behandling af erhvervede sygdomme
EE05691B1 (et) Ekspressioonivektorid ja nende rakendused
ATE80912T1 (de) Menschliche proteine des chinolinesterase-typs und ihre herstellung.
DE69929683D1 (de) Antisense modulierung von lfa-3
DK116687A (da) Farmaceutisk praeparat indeholdende aenovantroneae
DE69809785T2 (de) Verwendung eines retinoidids zur in vivo erhöhung der entkopplung des ucp2 proteins
ES2165727T3 (es) Composiciones de administracion por via oral con baja dosificacion de proteinas citotoxicas.
BRPI9917863B8 (pt) composição farmacêutica que é uma vacina
Matsui-Yuasa et al. Calcium ionophore A23187 induction of spermidine/spermine N 1‐acetyltransferase activity in bovine lymphocytes

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 7A. ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2021 DE 29/09/2009.